The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Clinical Practice Guideline for the Management of Infantile Hemangiomas
Abstract
Infantile hemangiomas (IHs) occur in as many as 5% of infants, making them the most common benign tumor of infancy. Most IHs are small, innocuous, self-resolving, and require no treatment. However, because of their size or location, a significant minority of IHs are potentially problematic. These include IHs that may cause permanent scarring and disfigurement (eg, facial IHs), hepatic or airway IHs, and IHs with the potential for functional impairment (eg, periorbital IHs), ulceration (that may cause pain or scarring), and associated underlying abnormalities (eg, intracranial and aortic arch vascular abnormalities accompanying a large facial IH). This clinical practice guideline for the management of IHs emphasizes several key concepts. It defines those IHs that are potentially higher risk and should prompt concern, and emphasizes increased vigilance, consideration of active treatment and, when appropriate, specialty consultation. It discusses the specific growth characteristics of IHs, that is, that the most rapid and significant growth occurs between 1 and 3 months of age and that growth is completed by 5 months of age in most cases. Because many IHs leave behind permanent skin changes, there is a window of opportunity to treat higher-risk IHs and optimize outcomes. Early intervention and/or referral (ideally by 1 month of age) is recommended for infants who have potentially problematic IHs. When systemic treatment is indicated, propranolol is the drug of choice at a dose of 2 to 3 mg/kg per day. Treatment typically is continued for at least 6 months and often is maintained until 12 months of age (occasionally longer). Topical timolol may be used to treat select small, thin, superficial IHs. Surgery and/or laser treatment are most useful for the treatment of residual skin changes after involution and, less commonly, may be considered earlier to treat some IHs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Propranolol for Severe Hemangiomas of Infancy
Léauté-Labrèze, C., de la Roque, E. D., Hubiche, T., Boralevi, F., Thambo, J.-B., & Taïeb, A. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0708819 · Cited by 2,374
American Society of Anesthesiologists
Marx, G. F. (1982) · Obstetric Anesthesia Digest · doi:10.1097/00132582-198203000-00028 · Cited by 1,899
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
Léauté-Labrèze, C., Hoeger, P., Mazereeuw-Hautier, J., Guibaud, L., Baselga, E., Posiunas, G., Phillips, R. J., Caceres, H., Lopez Gutierrez, J. C., Ballona, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404710 · Cited by 801
Self-citationGrowth Characteristics of Infantile Hemangiomas: Implications for Management
Chang, L. C., Haggstrom, A. N., Drolet, B. A., Baselga, E., Chamlin, S. L., Garzon, M. C., Horii, K. A., Lucky, A. W., Mancini, A. J., Metry, D. W., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-2767 · Cited by 694
Self-citationCellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi, K., Mulliken, J. B., Kozakewich, H. P., Rogers, R. A., Folkman, J., & Ezekowitz, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117241 · Cited by 648
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Drolet, B. A., Frommelt, P. C., Chamlin, S. L., Haggstrom, A., Bauman, N. M., Chiu, Y. E., Chun, R. H., Garzon, M. C., Holland, K. E., Liberman, L., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-1691 · Cited by 591
Self-citationPropranolol for Severe Infantile Hemangiomas: Follow-Up Report
Sans, V., de la Roque, E. D., Berge, J., Grenier, N., Boralevi, F., Mazereeuw-Hautier, J., Lipsker, D., Dupuis, E., Ezzedine, K., Vergnes, P., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-3458 · Cited by 568
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas
Huang, S. A., Tu, H. M., Harney, J. W., Venihaki, M., Butte, A. J., Kozakewich, H. P. W., Fishman, S. J., & Larsen, P. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430305 · Cited by 540
Storch, C. H., & Hoeger, P. H. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09848.x · Cited by 526
Mulliken, J. B., Fishman, S. J., & Burrows, P. E. (2000) · Current Problems in Surgery · doi:10.1016/s0011-3840(00)80013-1 · Cited by 504
The Natural History of the Strawberry Nevus
BOWERS, R. E. (1960) · Archives of Dermatology · doi:10.1001/archderm.1960.01580050009002 · Cited by 356
Oral Corticosteroid Use Is Effective for Cutaneous Hemangiomas
Bennett, M. L., Fleischer, A. B., Chamlin, S. L., & Frieden, I. J. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.9.1208 · Cited by 345
Self-citationMunden, A., Butschek, R., Tom, W. L., Marshall, J. S., Poeltler, D. M., Krohne, S. E., Alió, A. B., Ritter, M., Friedlander, D. F., Catanzarite, V., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12804 · Cited by 317
Diagnosis and Management of Infantile Hemangioma
Darrow, D. H., Greene, A. K., Mancini, A. J., Nopper, A. J., the SECTION ON DERMATOLOGY, S. O. O. A. N. S., Antaya, R. J., Cohen, B., Drolet, B. A., Fay, A., Fishman, S. J., et al. (2015) · Pediatrics · doi:10.1542/peds.2015-2485 · Cited by 293
Self-citationTreatment of infantile haemangiomas: recommendations of a European expert group
Hoeger, P. H., Harper, J. I., Baselga, E., Bonnet, D., Boon, L. M., Atti, M. L. C. D., Hachem, M. E., Oranje, A. P., Rubin, A. T., Weibel, L., et al. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2570-0 · Cited by 272
Batta, K., Goodyear, H. M., Moss, C., Williams, H. C., Hiller, L., & Waters, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09741-6 · Cited by 257
Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
Léauté-Labrèze, C., Boccara, O., Degrugillier-Chopinet, C., Mazereeuw‐Hautier, J., Prey, S., Lebbé, G., Gautier, S., Ortis, V., Lafon, M., Montagne, A., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0353 · Cited by 214
Untreated Hemangiomas: Growth Pattern and Residual Lesions
Bauland, C. G., Lüning, T. H., Smit, J. M., Zeebregts, C. J., & Spauwen, P. H. M. (2011) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e318208d2ac · Cited by 206
Early growth of infantile hemangiomas: what parents' photographs tell us
Tollefson, M. M., & Frieden, I. J. (2012) · Pediatrics · doi:10.1542/peds.2011-3683 · Cited by 199
Self-citationRisk for PHACE Syndrome in Infants With Large Facial Hemangiomas
Haggstrom, A. N., Garzon, M. C., Baselga, E., Chamlin, S. L., Frieden, I. J., Holland, K., Maguiness, S., Mancini, A. J., McCuaig, C., Metry, D. W., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-3166 · Cited by 191
Self-citationGrowing Up With a Facial Hemangioma: Parent and Child Coping and Adaptation
Tanner, J. L., Dechert, M. P., & Frieden, I. J. (1998) · Pediatrics · doi:10.1542/peds.101.3.446 · Cited by 181
Self-citationStrawberry hemangiomas; the natural history of the untreated lesion.
Jacobs, A. H. (1957) · PubMed Central · Cited by 175
Lessons from a liver hemangioma registry: subtype classification
Kulungowski, A. M., Alomari, A. I., Chawla, A., Christison-Lagay, E. R., & Fishman, S. J. (2012) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.10.037 · Cited by 171
Topical Timolol Gel for Infantile Hemangiomas: A Pilot Study
Pope, E., & Chakkittakandiyil, A. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.67 · Cited by 170
Ji, Y., Chen, S., Xu, C., Li, L., & Xiang, B. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13388 · Cited by 160
Haemangioma: clinical course, complications and management
Luu, M. N., & Frieden, I. J. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12436 · Cited by 145
Self-citationBiology of Infantile Hemangioma
Itinteang, T., Withers, A. H. J., Davis, P. F., & Tan, S. T. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00038 · Cited by 136
Topical Timolol Maleate Treatment of Infantile Hemangiomas
Puttgen, K. B., Lucky, A. W., Adams, D. M., Pope, E., McCuaig, C. C., Powell, J., Feigenbaum, D. F., Savva, Y., Baselga, E., Holland, K. E., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0355 · Cited by 136
Self-citationSpectrum of hepatic hemangiomas: management and outcome
Dickie, B., Dasgupta, R. A., Nair, R. R., Alonso, M. H., Ryckman, F. C., Tiao, G. M., Adams, D. M., & Azizkhan, R. G. (2009) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2008.10.021 · Cited by 134
Complications following pulsed dye laser treatment of superficial hemangiomas
Witman, P. M., Wagner, A. M., Scherer, K., Waner, M., & Frieden, I. J. (2006) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20294 · Cited by 125
Self-citationHorii, K. A., Drolet, B. A., Frieden, I. J., Baselga, E., Chamlin, S. L., Haggstrom, A. N., Holland, K. E., Mancini, A. J., McCuaig, C. C., Metry, D. W., et al. (2011) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2011.01420.x · Cited by 114
Self-citationInfantile Hemangioma--Mechanism(s) of Drug Action on a Vascular Tumor
Greenberger, S., & Bischoff, J. E. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006460 · Cited by 114
Early Growth of Infantile Hemangiomas: What Parents' Photographs Tell Us
(2012) · PEDIATRICS · doi:10.1542/peds.2011-3683d · Cited by 112
Infantile Hemangiomas With Minimal or Arrested Growth: A Retrospective Case Series
Suh, K.-Y., & Frieden, I. J. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.197 · Cited by 104
Self-citationPan, W., Li, P., Guo, Z., Huang, Q., & Gao, Y. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25453 · Cited by 102
Topical Timolol for Small Hemangiomas of Infancy
Moehrle, M., Léauté-Labrèze, C., Schmidt, V., et al. (2012) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2012.01723.x · Cited by 95
Management of Hemangiomas and Other Vascular Tumors
Greene, A. K. (2010) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2010.08.001 · Cited by 90
Self-citationLangley, A., & Pope, E. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13379 · Cited by 84
Adrenal Suppression After Corticosteroid Injection of Periocular Hemangiomas
Weiss, A. H. (1989) · American Journal of Ophthalmology · doi:10.1016/0002-9394(89)90497-2 · Cited by 81
Strawberry Hemangiomas; the Natural History of the Untreated Lesion
Jacobs, A. H., & SUTTON, L. E. (1957) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-195705000-00023 · Cited by 79
Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma
Frommelt, P. C., Juern, A. M., Siegel, D. H., Holland, K. E., Seefeldt, M., Yu, J., Uhing, M. R., Wade, K. C., & Drolet, B. A. (2016) · Pediatric Dermatology · doi:10.1111/pde.12869 · Cited by 75
Self-citationSafety of Propranolol Therapy for Severe Infantile Hemangioma
Prey, S., Voisard, J.-J., Delarue, A., Lebbé, G., Taïeb, A., Léauté-Labrèze, C., & Ezzedine, K. (2016) · JAMA · doi:10.1001/jama.2015.13969 · Cited by 72
Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas
Rialon, K. L., Murillo, R., Fevurly, R. D., Kulungowski, A. M., Christison-Lagay, E. R., Zurakowski, D., Kozakewich, H. P., Alomari, A. I., & Fishman, S. J. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.09.056 · Cited by 70
Moyakine, A. V., Kerstjens, J. M., Koulil, S. S., & van der Vleuten, C. J. M. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.02.1218 · Cited by 63
Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma
Goyal, R., Watts, P., Lane, C., Beck, L., & Gregory, J. W. (2004) · Ophthalmology · doi:10.1016/s0161-6420(03)00833-9 · Cited by 62
Child Development After Maternal Tocolysis with Beta-Sympathomimetic Drugs
Pitzer, M., Schmidt, M. H., Esser, G., & Laucht, M. (2001) · Child Psychiatry & Human Development · doi:10.1023/a:1026419720410 · Cited by 54
Zaher, H. A. E.-M., Rasheed, H. M., El-Komy, M. H. M., Hegazy, R. A., Gawdat, H. I., Halim, D. M. A., Hay, R. M. A., Hegazy, R., & Mohy, A. M. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.09.061 · Cited by 51
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study
Ji, Y., Wang, Q., Chen, S., Xiang, B., Xu, Z., Li, Y., Zhong, L., Jiang, X., & Yang, X. (2016) · Medicine · doi:10.1097/md.0000000000003908 · Cited by 50
Sharifpanah, F., Saliu, F., Bekhite, M. M., Wartenberg, M., & Sauer, H. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1976-8 · Cited by 48
Orbit and eyelid hemangiomas: Is there a relationship between location and ocular problems?
Dubois, J., Milot, J., Jaeger, B. I., McCuaig, C. C., Rousseau, É., & Powell, J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.042 · Cited by 45
Rialon, K. L., Murillo, R., Fevurly, R. D., Kulungowski, A. M., Zurakowski, D., Liang, M. G., Kozakewich, H. P., Alomari, A. I., & Fishman, S. J. (2015) · Pediatric Dermatology · doi:10.1111/pde.12656 · Cited by 42
Memory development: New questions and old
Neisser, U. (2003) · Developmental Review · doi:10.1016/j.dr.2003.09.002 · Cited by 38
Decreased eNOS Protein Expression in Involuting and Propranolol-Treated Hemangiomas
Dai, Y. (2012) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archoto.2011.1096 · Cited by 33
Ge, J., Zheng, J., Zhang, L., Yuan, W., & Zhao, H. (2016) · Scientific Reports · doi:10.1038/srep19765 · Cited by 26
Information about infantile hemangiomas on the Internet: How accurate is it?
Minzer-Conzetti, K., Garzón, M. C., Haggstrom, A. N., Horii, K. A., Mancini, A. J., Morel, K. D., Newell, B. D., Nopper, A. J., & Frieden, I. J. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.06.038 · Cited by 19
Self-citationRotter, A., Samorano, L. P., Labinas, G. H. O., Alvarenga, J. G., Rivitti‐Machado, M. C., Bouer, M., dos Santos, P. C. C., Silvestre, D. A. M., & de Oliveira, Z. N. P. (2016) · International Journal of Dermatology · doi:10.1111/ijd.13442 · Cited by 19
Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment
Mull, J. L., Chamlin, S. L., Lai, J., Beaumont, J. L., Cella, D. F., Rancour, E. A., Baselga, E., & Haggstrom, A. N. (2016) · Pediatric Dermatology · doi:10.1111/pde.13032 · Cited by 13
Reconsidering the Use of Propranolol in the Treatment of Cosmetic Infantile Hemangiomas
Bryan, B. A. (2013) · Angiology Open Access · doi:10.4172/2329-9495.1000e101 · Cited by 11
Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children
Techasatian, L., Komwilaisak, P., Panombualert, S., Uppala, R., & Jetsrisuparb, C. (2016) · Acta Paediatrica · doi:10.1111/apa.13378 · Cited by 9
How to use a controlled fast to investigate hypoglycaemia
Sreekantam, S., Preece, M. A., Vijay, S., Raiman, J., & Santra, S. (2016) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2015-308702 · Cited by 5
Yu, J., Maheshwari, M., Foy, A. B., Calkins, C. M., & Drolet, B. A. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.04.069 · Cited by 3
Cited by
De Lellis, L., Veschi, S., Tinari, N., Mokini, Z., Carradori, S., Brocco, D., Florio, R., Grassadonia, A., & Cama, A. (2021) · Cancers · doi:10.3390/cancers13163946 · Cited by 40
“Similarly, the beta-blocker (BB) propranolol used for cardiovascular disease has been widely used off-label to treat infantile hemangiomas (IHs) since its effectiveness was serendipitously reported in 2008, before receiving FDA approval in 2014 as a unique oral pediatric formulation for IH therapy [16,17].”
Background
Metadata
- Authors
- Krowchuk, D. P., Frieden, I. J., Mancini, A. J., Darrow, D. H., Blei, F., Greene, A. K., Annam, A., Baker, C. N., Frommelt, P. C., Hodak, A., Pate, B. M., Pelletier, J. L., Sandrock, D., Weinberg, S. T., Whelan, M. A., & HEMANGIOMAS, S. O. T. M. O. I.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2019-01-01
- Volume
- 143
- Issue
- 1
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2906007348
- Cited by
- 503
- References
- 61
- FWCI
- 34.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.